Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Press Releases

ReiThera Srl, the Ragon Institute and IAVI announce collaboration to advance highly networked T-cell HIV vaccine candidate towards Phase 1 clinical evaluation 

January 22, 2024

Novel HIV vaccine candidate based on Gorilla adenoviral vector (GRAd-HIV) funded by the Bill & Melinda Gates Foundation to alleviate the disease burden and improve the lives of the millions who lack access to prevention options.

Read more

Scientific Publications

Finding women in fishing communities around Lake Victoria: “Feasibility and acceptability of using phones and tracking devices”

Read more

Scientific Publications

Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya

Read more

Features

IAVI recommends new business models for increasing access to monoclonal antibodies

January 4, 2024

New approaches could help advance access to a promising medical innovation, consortium finds.

Read more

Scientific Publications

Turning the Gaze from Survive to Thrive for Children in India: Learnings from Two Case Studies

Read more

In The News

The Future of Tuberculosis Vaccines: Insights and Developments

Medriva

December 19, 2023

Read more

Features

Development of the candidate tuberculosis vaccine H56:IC31 ended based on early data from the Prevention of Recurrence TB Consortium

December 19, 2023

Vaccine well tolerated and demonstrated immunogenicity but did not provide protection against TB recurrence; participants being informed; further analysis continues.

Read more

Press Releases

IAVI and Zendal announce funding for efficacy trial of promising TB vaccine candidate in Africa

December 18, 2023

TB kills 1.3 million people a year and sickens more than 10 million people annually. A new TB vaccine is needed to reach the global End TB goals. MTBVAC is a highly promising vaccine candidate that has the potential to be used as an alternative to BCG vaccination in infants and for prevention of TB…

Read more